Background: Earlier invitro studies have observed that loss of E-cadherin is responsible for progression and metastasis of cancer by upregulation of c-Jun protein. There being lack of simultaneous evaluation of matrix metalloproteinase (MMP) -2 and -9, E-cadherin and c-Jun mRNA and protein.
Introduction
According to Global Cancer Statistics, oral cancer is one of the major health burden with 3,00,373 new oral cancer cases and 1,45,353 deaths worldwide (Ferlay et al., 2012) and is sixth most common malignancies in Asia (Rao et al., 2013) . The Indian subcontinent accounts for one-third of the world's oral cancer burden and late presentation many times with metastasis is common resulting into a strenuous problem (More et al., 2013; Khan et al., 2012 ).
E-cadherin, a key modulator in cell-cell adhesion has been known to play an important role in malignant transformation and in epithelial malignant transformation (EMT). E-cadherin loss has been observed in major metastasis (Kowalski et al., 2003) . It has been reported that just as a critical EMT event in decreasing the E-cadherin expression, the re-expression of E-cadherin is proposed to be the important hallmark of mesenchymal epithelial transformation (MET). Re-expression of Ecadherin also included MET in pancreatic tumor cell line and resulted in increased mRNA and protein expression of α and β-catenin (Yao et al., 2011) . Another plausible mechanism has been proposed to explain the changes in the cell phenotype, numerous signals in primary tumors actively promote the induction and continued expression of an EMT, whereas as tumor cells that leave the primary site may revert to the epithelial state due to the absence of EMT-inducing signals (Frisch et al., 1997) .
Investigators have proposed that MET during the progress of invasive and metastatic carcinoma, epithelial cancer cells can invade the surrounding tissue and metastasize, via functional cooperation between mesenchymal and more differentiated epithelial cancer cells and then participate in the formation of metastasis that are histopathologically similar to primary tumors (Tsuji et al., 2009 ). At present the process of metastasis is still poorly understood.
Matrix metalloproteinases (MMPs) play important role in metastasis and invasion by proteolytic degradation of extracellular matrix (ECM), disruption of cell-cell and cell matrix adhesion, migration and angiogenesis (Gialeli et al., 2011; Roy et al., 2009) . Initially, MMPs were thought to be important exclusively in invasion and metastasis, but recent studies have demonstrated that MMPs play a role in several steps during carcinogenesis (Yadav et al., 2014) . Earlier reports have documented the loss of E-cadherin, a cell adhesion molecule in oral precancerous conditions (OPC) also (Shah et al., 2009) . Further, MMPs are well-known modulators the cell-cell and cell-ECM interactions affecting both cell phenotype (epithelial mesenchymal transition) and increasing cell migration (Gialeli et al., 2011) . Hence, understanding MMPs in oral precancerous conditions would help in monitoring early events in tumorigenesis. Earlier reports from our laboratory and others have indicated elevated tissues and plasma levels of MMP-2 and MMP-9 in oral cancer patients (Singh et al., 2011; Tao et al., 2014) . Increase in the expression of MMP-2 from normal oral mucosa to dysplasia to oral cancer has been reported recently during oral carcinogenesis (Shrestha et al., 2014) . Earlier immunohistochemical analysis has shown significant immunoreactivity of MMP-2 and MMP-9 in oral lichen planus (Al-Rawi et al., 2014) . However, there are very few studies on MMPs in OPC documenting correlation of MMP-2 and MMP-9 with Ecadherin mRNA and protein simultaneously.
3 documented earlier that cytoskeleton dependent increase in c-Jun accumulation was not accompanied by an increase in CJUN mRNA but rather in the translatability of c-Jun transcript. Such a control was suggested to be due to internal ribosomal entry site (IRES) mediated translation (Polak et al., 2006) .
MMPs are the enzymes which plays an important role in metastasis and invasion by proteolytic degradation of ECM, disruption of cell-cell and cell-matrix adhesion, migration and angiogenesis (Vihenen et al., 2002; Gialeli et al., 2011; Roy et al., 2009) . These are released into the circulation and are found in body fluids. Hence MMPs were evaluated from plasma. Proteolytic degradation of E-cadherin is one of the mechanism by which E-cadherin mediated cell-cell adhesion can be ablated (Cavallaro et al., 2004) . A soluble 80 kD form of E-cadherin, have an active part in the invasive process during tumor progression (Navrocki-Raby et al., 2003) . Moreover, earlier studies have demonstrated that post-translational cleavage of native Ecad results in Mr 97000 fragment Ecad 97 . This is one of the mechanism by which E-cadherin function is abrogated. Hence in the present study, MMPs and E-cadherin were simultaneously analyzed.
To our knowledge, there are lack of invivo studies correlating simultaneously MMPs, protein and mRNA levels of E-cadherin and c-Jun. Hence the present study was undertaken for simultaneous evaluation of MMPs, mRNA and protein levels of E-cadherin and c-Jun in oral cancer. The evaluation of MMPs in patients with OPC would help in deciphering the role of MMPs during early neoplastic transformation.
Methodology

Subjects
The study was approved by Institutional Review Board of The Gujarat Cancer & Research Institute, Ahmedabad, Gujarat, India. Due consent was obtained from all the subjects who participated in the study. The subjects included in the study consisted of 100 healthy individuals (controls) who had no major illness in the recent past, 50 patients with OPC and 100 histopathologically proven untreated oral cavity cancer patients. The subjects were enrolled from The Gujarat Cancer & Research Institute, Ahmedabad. Out of 50 patients with OPC, 39 patients were with oral sub mucous fibrosis and 11 patients were with oral leukoplakia. Pathological tumor, node and metastasis (TNM) staging of malignant disease was performed as per American Joint Committee on Cancer (AJCC) norms (Greene et al., 2002) . The clinico-pathological details of oral cancer patients are mentioned in Table 1 . The oral cancer patients included in the study were followed for a period of 45 months and correlation of the molecular markers under the study with overall survival was analyzed.
Sample collection
Plasma was separated from the blood collected of 100 oral cancer patients, 50 patients with OPC and 100 healthy controls. Tissue samples from oral cancer patients (50 paired tissues) were collected on ice from operation theater immediately after surgical resection of the tumors. Adjacent normal tissue samples were selected from the tumor free margins at least 2-3 cm away from the tumor as defined by the pathologist. The tissue specimens were washed with ice-cold phosphate Bhairavi N. Vajaria, Kinjal R. Patel, Rasheedunnisa Begum, Franky D. Shah, Jayendra B. Patel, Geeta M. Joshi, and Prabhudas S. Patel / American Journal of Oral medicine (2017) Vol. 3 No. 1 pp. 1-24 4 buffer saline (PBS: pH 7.4) and were stored at -80°C until analyzed. For RNA analysis, RNA 'later' (Qiagen, Valencia, CA, USA) was added to the tissues and were stored at -80°C until analyzed. 
Total Proteins
Total protein levels from plasma euglobulin fraction / tissue lysates were determined using the Folin Lowry's method (Lowry et al., 1951) . The standard curve was prepared using bovine serum Bhairavi N. Vajaria, Kinjal R. Patel, Rasheedunnisa Begum, Franky D. Shah, Jayendra B. Patel, Geeta M. Joshi, and Prabhudas S. Patel / American Journal of Oral medicine (2017) Vol. 3 No. 1 pp. 1-24 5 albumin (Sigma, USA) as standard in concentration range of 10-60μg.
Gelatin zymography
Gelatin Zymography was performed from plasma euglobulin fraction. For euglobulin fraction, 0.1 ml of plasma was mixed with 0.9 ml of DDW. To this 40µl of 1% Acetic acid was added and incubated at 0°C for 1 hour. Further the solution was centrifuged at 5000 rpm for 10 minutes in cooling centrifuge. The supernatant was discarded. Further the pellet (euglobulin) was dissolved in 0.1 ml phosphate buffer saline. Protein estimation of dissolved fraction was performed by FolinLowry's method. Equal amount i.e. 100µg plasma euglobulin was mixed with sample buffer and loaded on loaded on 7.5% SDS-PAGE (containing 0.5mg/ml gelatin) and gelatin zymography was performed by methodology as described by Lorenzo et al. (Lorenzo et al., 1992) . These zymograms were quantitated using gel documentation system (Alpha Innotech, USA). The integrated density value (IDV) i.e. the sum of all the pixel values after background correction, was determined for each proteinase activity. The reproducibility of the samples was checked by running the samples in same gels as well as in different gels.
Semi-quantitative RT-PCR
RNA was isolated from all the tissue (paired adjacent normal and malignant, n=50) samples collected from oral cancer patients using RNA isolation kit (Qiagen, Valencia, CA, USA) and stored at -80 0 C. Semi-quantitative RT-PCR from transcripts was carried out using specific primer sequences ECAD (Zhang et al., 2007) , CJUN (Chatzistamou et al., 2000) , βACTIN:F5'-GGTCACCCACACTGTGCCCAT-3';R5'-GGATGCCACAGGACTCCATGC-3'. βACTIN was used as internal control in all the reactions and RT-PCR was carried out using one-step RT-PCR kit (Qiagen, Valencia, CA, USA). The reaction products were electrophoresed on 1.5% agarose gels containing ethidium bromide and gels were analyzed densitometrically using gel documentation system (Alpha Innotech, USA). The relative mRNA expression was expressed by normalizing to βACTIN.
Western blot
Tissue lysate was prepared by lysis of 50 mg of tissue with lysis buffer. After centrifugation, the lysate supernatant was taken in another fresh microcentrifuge tube and its total protein content was estimated (Lowry et al., 1951) . The running gel of 10% and 12% were prepared for E-cadherin and c-Jun protein, respectively. The tissue lysates equivalent to 100g protein was loaded. The proteins were separated on SDS-PAGE under denaturing and reducing conditions at constant voltage. After electro-transfer, the membrane was incubated in 5%w/v blocking reagent for 1 h at room temperature. After washing, the membrane was incubated overnight with primary antibody i.e. anti E-cadherin antibody i.e. mouse monoclonal HECD1 antibody (Calbiochem, USA), anti-c-Jun G-4 mouse monoclonal antibody (Santacruz Biotech) and β-Actin antibody (Santacruz Biotech, USA) with gentle shaking. The membrane was rinsed thrice with TBS-T (1x15 min and 2x5 min) and then incubated with appropriate HRP conjugated anti-mouse secondary antibody (1:1000 dilution in TBS-T) for 2 hrs with gentle shaking. The detection was performed by autoradiography (chemiluminescence method) using ECL western blotting detection kit (GE Health care) by capturing luminescensce on light sensitive hyperfilm. The densitometric analysis of protein band Bhairavi N. Vajaria, Kinjal R. Patel, Rasheedunnisa Begum, Franky D. Shah, Jayendra B. Patel, Geeta M. Joshi, and Prabhudas S. Patel / American Journal of Oral medicine (2017) Vol. 3 No. 1 pp. 1-24 6 was performed using densitometer (Alpha Innotech Inc) and was expressed as IDV i.e. the sum of all the pixel values after background correction.
Statistical analysis
Statistical analysis of the data was performed using statistical package for social science (SPSS) software version 17.0. Student's paired 't' test was used to compare the mRNA and protein levels of E-cadherin and c-Jun between adjacent normal and malignant tissues of the oral cancer patients. Student's independent 't' test was performed to assess the levels of significance of markers with various clinico-pathological parameters. Pearson's correlation analysis was performed to assess the correlation between various forms of plasma MMPs, mRNA and protein expression of E-cadherin and c-Jun. Receiver's operating characteristic's (ROC) curve analysis was performed to obtain optimal cut-off point for survival analysis. Kaplan-Meier survival analysis was used to analyze correlation of the markers with overall survival and significance of differences in survival rates was analyzed by Log rank test. Multivariate analysis was performed to correlate the markers simultaneously with various clinico-pathological parameters. The values were expressed as the Mean ± Standard Error of Mean (SEM). 'p' value less than 0.05 was considered to be statistically significant. Plasma MMPs were estimated from 100 controls, 50 patients with OPC and 100 oral cancer patients. Fig. 1A and oral cancer patients. As depicted in Fig. 1B and 1C, the levels of pro, active and total MMP-2 and MMP-9 were significantly higher in patients with OPC (p<0.0001) as compared to the controls. Active MMP-2, pro and active MMP-9, total MMP-2 and MMP-9 were significantly higher in oral cancer patients (p<0.0001, p<0.0001, p=0.051, p<0.0001, respectively) as compared to the controls (Table 2 ) by student's independent t' test. Similarly, active MMP-2 was observed to be significantly higher in oral cancer patients as compared to patients with OPC (p=0.025). 
Results
Comparison of plasma pro, active and total MMP-2 and MMP-9 in controls, patients with OPC and oral cancer patients
ECAD and CJUN mRNA expression in malignant and adjacent normal tissues
ECAD and CJUN mRNA expression was estimated from 50 paired tissues by semiquantitative RT-PCR using ECAD and CJUN specific primers and levels were normalized to βACTIN expression. Fig.  2A shows the band of 420bp i.e. of ECAD mRNA expression. The analysis by paired 't' test revealed that ECAD mRNA levels were comparable between malignant and adjacent normal tissues (Fig. 2B) . Fig. 3A is the representative pattern of CJUN mRNA expression which shows the band of 404bp of CJUN. Fig. 3B depicts that the levels of CJUN mRNA were comparable between paired malignant and adjacent normal tissues by paired 't' test. The levels of c-Jun protein were compared in malignant and adjacent normal tissues of oral cancer patients. Fig. 5A is the representative of c-Jun protein in malignant and adjacent normal tissues. The bar chart in Fig. 5B depicts that the levels of c-Jun protein were found to be significantly higher (p=0.031) in malignant tissues as compared to adjacent normal tissues by paired t-test. 
Correlation of MMP-2, MMP-9, mRNA and protein expression of E-cadherin and c-Jun with various clinicopathological parameters
The levels of different forms of MMPs were further compared in early and advanced stage of disease. The levels of pro MMP-2, active MMP-2, pro MMP-9, Total MMP-2 and total MMP-9 were observed to be higher in advanced stage as compared to early stage of the disease and levels were significant for pro MMP-2 (p=0.003) by student's independent 't' test. An increasing trend of plasma Bhairavi N. Vajaria, Kinjal R. Patel, Rasheedunnisa Begum, Franky D. Shah, Jayendra B. Patel, Geeta M. Joshi, and Prabhudas S. Patel / American Journal of Oral medicine (2017) Vol. 3 No. 1 pp. 1-24 13 active MMP-2, pro MMP-9, active MMP-9, total MMP-2, total MMP-9 was observed from well to moderate to poorly differentiated tumors.
Multivariate analysis was performed to correlate the markers with various clinico-pathological parameters like stage, differentiation, nuclear grade, metastasis, lymphovascular permeation, lymphocytic infiltration, perineural invasion and infiltration. The results are as depicted in Table 3 . Multivariate analysis depicted significant correlation of pro MMP-2, pro MMP-9, active MMP-9 and total MMP-9 (p=0.007, p=0.052, p=0.052, p=0.050, respectively) with nuclear grade. Active MMP-2 and total MMP-2 was observed to be significantly associated with lymphovascular permeation (p=0.053 and p=0.052 respectively). Pro MMP-2 was found to be significantly associated with perineural invasion (p=0.021) and infiltration (p=0.053).
Moreover, ECAD mRNA expression was found to be lower in infiltrating tumors as compared to non-infiltrating tumors by student's independent 't' test, however levels were non-significant. Multivariate analysis showed significant association of ECAD mRNA with differentiation and stage of disease (p=0.05 and p=0.048, respectively). A decreasing trend of ECAD mRNA levels was observed from well to moderate to poorly differentiated tumors, however levels were nonsignificant. The levels were found to be significantly decreased (p=0.041) in moderately differentiated tumors as compared to well differentiated tumors by student's independent 't' test.
The results by independent 't' test revealed that the levels of truncated E-cadherin protein (97 kDa) were found to be higher in advanced stage of disease as compared to early stage (p=0.313) of disease. The levels of truncated E-cadherin protein were found to be increased in infiltrative tumors as compared to non-infiltrative tumors (p=0.121) and were also significantly higher in metastatic tumors as compared to non-metastatic tumors (p<0.0001). Multivariate analysis depicted significant association of truncated E-cadherin protein with metastasis (p<0.0001). Table 3 shows the results of multivariate analysis which depicted significant association of CJUN mRNA with the stage of disease (p=0.044). c-Jun protein expression was found to be higher in moderately differentiated tumors as compared to well differentiated tumors (p=0.258), however levels were non-significant by student's independent 't' test. 
ROC curve analysis of plasma pro, active and total MMP-2 and MMP-9
ROC curves were constructed for plasma pro, active and total MMP-2 and MMP-9 (Table 4 ). The results revealed that pro MMP-2, active MMP-2, pro MMP-9, active MMP-9, total MMP-2 and total MMP-9 could significantly distinguish controls and patients with OPC (p<0.0001, p<0.0001, p<0.0001, p=0.002, p<00.001, p<0.0001 respectively). Pro MMP-2, active MMP-2, pro MMP-9, total MMP-2 and total MMP-9 could significantly discriminate controls and oral cancer patients (p<0.0001, p<0.0001, p<0.0001, p<0.0001, p=0.006 respectively). Moreover, pro MMP-2, pro MMP-9, active MMP-9 and total MMP-9 could significantly distinguish patients with OPC and oral cancer patients (p<0.0001, p<0.0001, p=0.003 and p<0.0001, respectively). 
Pearson's correlation analysis of plasma MMPs with E-cadherin and c-Jun protein and mRNA
As depicted in Table 5 , truncated E-cadherin protein showed significant positive correlation with plasma pro MMP-2 (r=0.948, p<0.0001), plasma active MMP-2 (r=0.748, p=0.008), plasma active MMP-9 (r=0.873, p<0.0001), plasma total MMP-2 (r=0.778, p=0.005) and activation ratio MMP-2 (r=0.062, p=0.857). Moreover, all the forms of plasma MMPs were positively correlated with c-Jun protein and mRNA levels, although the correlation was observed to be non-significant. Plasma active MMP-2, pro MMP-9, active MMP-9, total MMP-9 and activation ratio MMP-2 were observed to be negatively correlated with ECAD mRNA, however, the correlation was non-significant.
Kaplan Meier's survival analysis of different forms of plasma MMPs, E-cadherin and c-Jun protein and mRNA with overall survival
Kaplan Meier's survival analysis was carried out to estimate the overall survival of oral cancer patients. Survival analysis depicted that the oral cancer patients with values above ROC cut-off of active MMP-2, pro MMP-9, total MMP-2 and total MMP-9 (Table 6 ) had lower overall survival as compared to those with values below ROC cut-off. Kaplan Meier's survival analysis of ECAD mRNA depicted lower survival with lower ECAD mRNA levels (values below ROC cut-off) (Fig. 6A) . Fig. 6B depicted that higher levels of truncated Ecadherin protein (above ROC cutoff) had lower overall survival as compared to lower levels (below cut-off). The ROC cut-off values with sensitivity, specificity and AUC along with Log Rank Chi 2 value are as mentioned in Table 6 . Kaplan Meier survival curves were compared by Log-rank analysis and ECAD mRNA and truncated E-cadherin protein expression levels in oral cancer patients were depicted as higher (above ROC cut-off) or lower levels (below ROC cut-off). The values above and below cutoff are expressed as survival in months ± SEM. Table 6 revealed that higher values of c-Jun protein expression depicted significant association with overall survival (Chi 2 =7.038, p=0.008).
Kaplan Meier's Survival mean estimate of E-cadherin protein, c-Jun, pro MMP-2, activation ratio MMP-2, activation ratio MMP-9 cannot be computed as all the cases were censored. 
Discussion
Loss of E-cadherin mediated cell-cell adhesion plays a key role in metastasis. Recently cell lines based studies have documented that loss of E-cadherin mediates increase in c-Jun protein with no corresponding increase in c-Jun mRNA in melanoma and glioblastoma (Blau et al., 2012; Splangler et al., 2011) . As MMPs play a crucial role in disruption of cell-cell adhesion, the present study was designed for simultaneous evaluation of E-cadherin and c-Jun protein and mRNA expression along with MMPs in oral cancer patients. To our knowledge there are lack of studies evaluating simultaneously all these parameters in oral cancer. Initially MMPs were thought to be important exclusively in invasion and metastasis, but recent studies have demonstrated that MMPs play a role in several steps during carcinogenesis (Yadav et al., 2014; Shrestha et al., 2014) . In the present study, the levels of pro, active and total MMP-2 and MMP-9 were significantly higher in patients with OPC as compared to controls. Active MMP-2 was observed to be significantly higher in oral cancer patients as compared to patients with OPC. Increase in the expression of MMP-2 and MMP-9 have been recently reported in oral precancerous conditions and various intermediate stages of oral carcinogenensis (Shrestha et al., 2014; Al-Rawi et al., 2014) . In the present study, the results demonstrated significant higher levels of active MMP-2, pro and active MMP-9, total MMP-2 and MMP-9 in oral cancer patients as compared to controls. The results were consistent with our previous results which depicted upregulation of MMP-2 and MMP-9 in oral cancer (Shrestha et al., 2014) . Earlier studies have observed that MMP-9 expression was associated with tumor metastasis of oral squamous cell carcinoma (OSCC) Specenier et al., 2015) . Bhairavi N. Vajaria, Kinjal R. Patel, Rasheedunnisa Begum, Franky D. Shah, Jayendra B. Patel, Geeta M. Joshi, and Prabhudas S. Patel / American Journal of Oral medicine (2017) Vol. 3 No. 1 pp. 1-24 19 The present study depicted higher levels of pro MMP-2, active MMP-2, pro MMP-9, total MMP-2 and total MMP-9 in advanced stage as compared to early stage of disease and levels were significant for pro MMP-2. Earlier studies have shown that high tumor and stromal MMP-2 and MMP-9 expression was significantly associated with positive lymph node metastasis (Fan et al., 2012) and is linked to poor clinical outcomes (Zheng et al., 2015) . In the present study, survival analysis depicted that higher values of active MMP-2, pro MMP-9, total MMP-2 and total MMP-9 was associated with lower overall survival. Earlier studies have shown that overall survival was significantly shorter in patients with high tumor and stromal MMP-2 and MMP-9 expression (Fan et al., 2012) .
Western blot analysis of E-cadherin revealed significant increase of truncated 97 kDa E-cadherin protein in malignant tissues as compared to adjacent normal tissues. Earlier 97 kDa, a truncated form of mature 120 kDa E-cadherin has been documented to be significantly increased in prostate cancer tumors (Rashid et al., 2001) . Diminished E-cadherin levels have been reported in oral cancer (Shah et al., 2009 , Vered et al., 2012 , De Freitas Silva et al., 2014 , Zhou et al., 2015 Earlier studies have reported decreased E-cadherin levels in oral precancerous conditions (Freitas Silva et al., 2014 .
The levels of truncated E-cadherin protein (97 kDa) were found to be higher in advanced disease, infiltrative and metastatic tumors as compared to early disease, non-infiltrative and non-metastatic tumors respectively. The data were consistent with our earlier studies which earlier have reported positive correlation of 97 kDa truncated E-cadherin protein with advanced stage and lymph node metastasis (Shah et al., 2009 ). Earlier studies have documented E-cadherin in non-tumor epithelium adjacent to oral cancer as a risk marker for the development of multiple tumors (Zhou et al., 2015) . However, no correlation between loss of E-cadherin and degree of dysplasia/ tumor differentiation has also been observed earlier (Sridevi et al., 2015) .
The levels of ECAD mRNA were analyzed by semiquantitative RT-PCR and the results revealed that the ECAD mRNA levels were comparable between malignant and adjacent normal tissues. Earlier studies have reported downregulation of ECAD mRNA levels. No significant difference was observed in normal and tumor tissues in breast cancer patients in earlier studies by Goyal et al. (Goyal et al., 2008) . Lower E-cadherin mRNA and protein levels have been reported in colorectal cancer (Garinis et al., 2003) . Earlier reports have suggested that promoter hypermethylation reduces the expression of E-cadherin leading to increased metastasis (Kwon et al. 2010) . Moreover, in the present study, ECAD mRNA expression was found to be lower in infiltrating tumors as compared to non-infiltrating tumors. Multivariate analysis showed significant association of ECAD mRNA with differentiation and stage of disease. Earlier studies have reported that mRNA levels of ECAD decreased significantly in metastatic tumors as compared to non-metastatic tumors in nasopharyngeal carcinoma (Kaur et al., 2009) . In the present study, Kaplan Meir's survival analysis indicated that lower ECAD mRNA expression depicted lower survival. Earlier studies by Dorudi et al. (Dorudi et al., 1995) have documented that colorectal cancer patients with higher levels of ECAD mRNA had higher overall survival (greater than 5 years). Earlier studies in various types of carcinomas, including oral squamous cell carcinoma (OSCC), by immunohistochemical analysis have shown that reduced expression of E-cadherin protein was associated with poor prognosis (Luo et al., 2014) , however its mRNA levels were not studied.
In the present study, the levels of CJUN mRNA were comparable between paired malignant and adjacent normal tissues. Recent cell lines based studies have shown that there was no change in CJUN mRNA levels in glioblastoma and melanoma, but there was an increase in translatability of CJUN transcript which was suggested to be due IRES mediated translation (Blau et al., 2012; Splangler et al., 2011) . In the present study, it was observed that the levels of c-Jun protein were found to be significantly higher in malignant tissues as compared to adjacent normal tissues. Earlier studies have observed higher expression of c-Jun protein oral cancer tissues (Mishra et al., 2010) .
Another immunohistochemical analysis has shown that nuclear localization of c-Jun protein was linked to development of oral cancer (De Sousa et al., 2002) . In the present study, the higher values of c-Jun protein were significantly associated with reduced overall survival. Earlier studies have reported increased positive pc-Jun staining which served as a marker for worse prognosis in OSCC (Kuo et al., 2006) and oral leukoplakias (Lima et al., 2015) .
The present study depicted a significant positive correlation between truncated E-cadherin protein and CJUN mRNA. Moreover, ECAD mRNA was observed to be positively correlated with CJUN mRNA. However, there are lack of reports on simultaneous evaluation of mRNA and protein expression of E-cadherin and c-Jun in oral cancer. Earlier studies have observed that loss of E-cadherin mediated cell-cell adhesion is responsible for upregulation of c-Jun protein, which might be due to IRES mediated translation (Knirsh et al., 2009 ). In the present study, truncated E-cadherin protein was observed to be positively correlated with c-Jun protein. Therefore, we hypothesize that increased truncation of E-cadherin protein might be responsible for upregulation of c-Jun protein in oral cancer. As we have observed no change in c-Jun mRNA, we hypothesize that an increase in c-Jun protein observed in present study might be due to IRES mediated translation. Moreover, truncated E-cadherin protein showed significant positive correlation with plasma pro MMP-2, plasma active MMP-2, plasma active MMP-9, plasma total MMP-2 and activation ratio MMP-2. Hence, overall results suggest that increase expression of MMPs causes loss of cell-cell adhesion by increased truncation of E-cadherin protein. The loss of E-cadherin is subsequently responsible for increased c-Jun protein in oral cancer.
In conclusion, MMPs plays an important role in disruption of cell-cell adhesion by loss of E-cadherin protein, which subsequently is responsible for increase in c-Jun protein in oral cancer. c-Jun may serve as an predictive marker for evaluating prognosis of oral cancer patients and may serve as an important therapeutic drug target for future interventions. Moreover, significant changes in MMPs observed in patients with OPC highlights the role of MMPs in early progression of oral cancer.
